Summary:
Click image to enlarge
The SOTA studies are evaluating an investigational oral tablet compared to placebo that may help manage your blood glucose levels.Participants will be required to attend regular office visits throughout the duration of the SOTA studies. You will be given glucose monitoring supplies and asked to record your blood glucose levels in a diary. Participants will be required to fast, or go without food for 8 hours, prior to some visits during the study. You may also have the following assessments evaluated: physical exam, vital signs, blood or urine tests; and diet, exercise, and health education.
You will be randomly assigned to receive either the investigational oral tablet or a placebo. This oral tablet will be taken once before the first meal of the day. The placebo looks like the study drug, but has no active drug in it. Neither you nor the person administering the drug will know if you are receiving the active drug or the placebo.
Qualified Participants Must:
• Be diagnosed with Type 2 Diabetes
•
Be 18 years of age or older
•
Have HbA1c levels 7.5-10.5%
•
Be taking Basal Insulin alone or with up to two oral anti-diabetes medications
Qualified Participants May Receive:
This investigational oral tablet, when combined with diet and exercise, may help manage blood glucose levels in people with Type 2 Diabetes (T2D). Additionally, the knowledge gained from the SOTA studies may help other people with T2D in the future.
The clinical research team will discuss all study risks with you and answer any additional questions you may have. Eligible participants will receive study related medical care at no cost.
Compensation for time and travel to those who qualify.